Mutaflor Suspension Suspension (Oral)
Escherichia coli strain Nissle 1917 corresponding to 10^8 viable cells (CFU)
0.05ml/ml
SYNERGY PHARMA
| Pack size | 10 Polyethylene Ampoules [5's strip x 2] in Sachets x 1ml |
|---|---|
| Dispensing mode | POM |
| Source | UAE |
| Agent | UNIQUE LIFE MEDICINES TRADING |
| Retail Price | 176.00 AED |
Available as:
Indications
Mutaflor Suspension Suspension (Oral) is used for:
Efficacy of Mutaflor for a variety of inflammatory bowel diseases has been tested through 80 years of clinical experience. There are numerous double-blind placebo-controlled studies showing the efficacy of Mutaflor in the treatment and prevention of gastrointestinal disorders. uSED FOR TREATMENT OF Ulcerative colitis, CHRONIC CONSTIPATION, Crohn's disease, POUCHITIS, IRRITABLE BOWEL SYNDROME.
Adult Dose
Child Dose
Renal Dose
Administration
Contra Indications
Precautions
Pregnancy-Lactation
Interactions
Adverse Effects
Side effects of Escherichia coli strain Nissle 1917 corresponding to 10^8 viable cells (CFU) :
Mechanism of Action
Note
Mutaflor Suspension 0.05ml/ml Suspension (Oral) manufactured by SYNERGY PHARMA. Its generic name is Escherichia coli strain Nissle 1917 corresponding to 10^8 viable cells (CFU). Mutaflor Suspension is availble in United Arab Emirates.
Farmaco UAE drug index information on Mutaflor Suspension Suspension (Oral) is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.